First Eagle Investment Management LLC bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 517,323 shares of the construction company’s stock, valued at approximately $3,601,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Aspen Aerogels by 0.5% during the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock valued at $31,392,000 after acquiring an additional 22,686 shares in the last quarter. Federated Hermes Inc. purchased a new stake in Aspen Aerogels during the 2nd quarter valued at $10,459,000. Geode Capital Management LLC increased its holdings in shares of Aspen Aerogels by 4.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,582,742 shares of the construction company’s stock worth $9,371,000 after purchasing an additional 66,967 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Aspen Aerogels by 8.3% in the third quarter. JPMorgan Chase & Co. now owns 1,349,749 shares of the construction company’s stock worth $9,394,000 after purchasing an additional 103,243 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently commented on ASPN. Barclays reduced their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. TD Cowen lowered their price objective on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Zacks Research upgraded shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Roth Mkm decreased their target price on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $4.50.
Aspen Aerogels Stock Up 0.3%
ASPN opened at $3.35 on Thursday. The firm’s 50 day simple moving average is $3.35 and its two-hundred day simple moving average is $4.95. The company has a market capitalization of $276.88 million, a PE ratio of -0.71 and a beta of 2.99. Aspen Aerogels, Inc. has a 1-year low of $2.30 and a 1-year high of $9.78. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The business had revenue of $41.34 million for the quarter, compared to the consensus estimate of $44.25 million. During the same period in the previous year, the firm earned $0.14 EPS. The company’s revenue was down 66.4% on a year-over-year basis. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. As a group, equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Recommended Stories
- Five stocks we like better than Aspen Aerogels
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
